• NBE-Therapeutics Closes USD 22M Series C Financing Round b3cnewswire
    January 17, 2020
    NBE-Therapeutics AG today announces the closing of a USD 22M Series C financing round, led by its existing shareholders Boehringer Ingelheim Venture Fund and the PPF Group and with participation from all private shareholders.
PharmaSources Customer Service